Comment on: 'Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients'.

Garza-Santiago, Esmeralda; Ortiz-Hernández, Alejandro; Kammar-García, Ashuin; Mancilla-Galindo, Javier

Garza-Santiago, Esmeralda; Ortiz-Hernández, Alejandro; Kammar-García, Ashuin; Mancilla-Galindo, Javier.

Garza-Santiago E; Facultad de Medicina, Universidad del Valle de México. Avenida México 101, Col del Bosque, Villahermosa, Tabasco, 86180, Mexico.
Ortiz-Hernández A; Facultad de Medicina, Universidad Autónoma de San Luis Potosí. Alvaro Obregon 64, Centro, San Luis, San Luis Potosí, 78300, Mexico.
Kammar-García A; Dirección de Investigación, Instituto Nacional de Geriatría. Anillo Perif 2767, San Jerónimo Lídice, La Magdalena Contreras, Mexico City, 10200, Mexico.
Mancilla-Galindo J; Facultad de Medicina, Universidad Nacional Autónoma de México. Circuito Escolar 411A, Copilco Universidad, Coyoacán, Mexico City, 04360, Mexico.

Future Microbiol ; 17: 1277-1281, 2022 11.

Article in English | MEDLINE | ID: covidwho-2039612

Subject(s)

COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hypoxia/drug therapy; Ivermectin/therapeutic use; Leprostatic Agents/therapeutic use; SARS-CoV-2

Keywords

COVID-19; coronavirus; ivermectin; research design

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Experimental Studies Limits: Humans Language: English Journal: Future Microbiol Journal subject: Microbiology Year: 2022 Document Type: Article Affiliation country: Fmb-2022-0080

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google